CWM
BIIB icon

Cornerstone Wealth Management’s Biogen BIIB Stock Holding History

Cornerstone Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-11,240
Closed -$38K – 1320
2018
Q2 		$38K Buy
+11,240
New +$3.16M ﹤0.01% 1433

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Cornerstone Wealth Management's BIIB Position: Q3 2018 in Review

Cornerstone Wealth Management sold out of Biogen (BIIB) in Q3 2018, closing a stake of 11,240 shares — an estimated $38K sold.

Cornerstone Wealth Management first reported a position in BIIB in Q2 2018 and held it in 1 quarter. The position peaked at $38K in Q2 2018. 1,145 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

  • Cornerstone Wealth Management reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
  • Cornerstone Wealth Management sold 11,240 Biogen shares in Q3 2018, an estimated $38K.
  • Cornerstone Wealth Management first reported a position in Biogen in Q2 2018 and held it in 1 quarter.
  • Cornerstone Wealth Management's Biogen position peaked at $38K in Q2 2018.
  • 1,145 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Cornerstone Wealth Management's 13F filing for Q3 2018, filed 19 Oct 2018.